Series A Oncology Companies

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.

Fuse Oncology provides business and clinical intelligence solution for radiation oncology.

Beads is a hospice housing organisation that provides hospice housing and independent living facility.

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Trial Library is an oncology clinical trials company.

T-CURX develops personalized T cell therapies for cancer, leveraging a proprietary platform for improved patient outcomes.

Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

DeuterOncology is a preclinical-stage biotech company.

Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.

Macomics is an immuno-oncology company.

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

BAKX Therapeutics is a provider of cancer treatment.

Haystack Oncology enables precision oncology to optimize treatment strategies.

Preveta is a SaaS care navigation platform for specialty and oncology care.

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.